We compared prostate cancer with Burkitt's lymphoma because both harbor a recurrent translocation that leads to the over expression of two known oncogenes: c-MYC for Burkitt's lymphoma and ERG for prostate cancer. Here, ERG is linked to prostate carcinoma.